Acceptability of routine HIV counselling and testing, and HIV seroprevalence in Ugandan hospitals

Bulletin of the World Health Organization

Volumn 86, Issue 4, 2008, Pages 302-309

  Wanyenze, Rhoda K ^a   Nawavvu, Cecilia ^a   Namale, Alice S ^b   Mayanja, Bernard ^a   Bunnell, Rebecca ^b   Abang, Betty ^b   Amanyire, Gideon ^a   Sewankambo, Nelson K ^a   Kamya, Moses R ^a  

^a Mulago Mbarara Teaching Hospitals' Joint AIDS Program (MJAP)   (Uganda)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE PREVALENCE; HUMAN IMMUNODEFICIENCY VIRUS; INFECTIOUS DISEASE; TESTING METHOD;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL EXAMINATION; CONTROLLED STUDY; FEMALE; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; PATIENT COUNSELING; SEROPREVALENCE; UGANDA;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; DIRECTIVE COUNSELING; FEMALE; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV SEROPREVALENCE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PATIENT ACCEPTANCE OF HEALTH CARE; SEXUAL PARTNERS; UGANDA;

AFRICA; EAST AFRICA; SUB-SAHARAN AFRICA; UGANDA;

EID: 42049107714     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.07.042580     Document Type: Article

References (33)

1. Baggaly R. The impact of voluntary counselling and testing: a global review of the benefits and challenges. Geneva: UNAIDS; 2001 (UNAIDS/01.32E).
2. Forsyth AD, Coates TJ, Grinstead OA, Sangiwa G, Balmer D, Kamenga MC, et al. HIV infection and pregnancy status among adults attending voluntary counselling and testing in 2 developing countries. Am J Public Health 2002;92:1795-800.
3. Efficacy of voluntary HIV-1 counselling and testing in individuals and couples in Kenya, Tanzania, and Trinidad: a randomized trial. The Voluntary HIV-1 Counselling and Testing Efficacy Study Group. Lancet 2000;356:103-12. PMID:10963246 doi:10.1016/S0140-6736(00)02446-6
4. De Zoysa I, Phillips KA, Kamenga MC, O'Reilly KR, Sweat MD, White RA, et al. Role of HIV counselling and testing in changing risk behavior in developing countries. AIDS 1995;9(Suppl A):S95-101.
5. Gresenguet G, Sehonou J, Bassirou B, Longo Jde D, Malkin JE, Brogan T, et al. Voluntary HIV counselling and testing: experience among the sexually active population in Bangui, Central African Republic. J Acquir Immune Defic Syndr 2002;31:106-14.
6. De Cock KM, Mbori-Ngacha D, Marum E. Shadow on the continent: public health and HIV/AIDS in Africa in the 21st century. Lancet 2002;360:67-72. PMID:12114058 doi:10.1016/S0140-6736(02)09337-6
7. De Cock KM, Marum E, Mbori-Ngacha D. A sero-status approach to HIV/AIDS prevention and care in Africa. Lancet 2003;362:1847-9. PMID:14654325 doi:10.1016/S0140-6736(03)14906-9
8. Emergency scale-up of antiretroviral therapy in resource-limited settings: technical and operational recommendations to achieve 3 by 5. Report from: WHO/UNAIDS Zambia consultation, 18-21 November 2003, Lusaka, Zambia. Geneva: WHO/UNAIDS; 2003.
9. Treating 3 million by 2005. Making it happen. The WHO strategy. The WHO and UNAIDS global initiative to provide antiretroviral therapy to 3 million people with HIV/AIDS in developing countries by the end of 2005. Geneva: WHO; 2003.
10. Provisional WHO/UNAIDS Secretariat recommendations on the use of Cotrimoxazole Prophylaxis in adults and children living with HIV/AIDS in Africa. Geneva: UNAIDS; 2000.
11. Mermin J, Lule J, Ekwaru JP, Malamba S, Downing R, Ransom R, et al. Effect of co-trimoxazole prophylaxis on morbidity, mortality, CD4-cell count, and viral load in HIV infection in rural Uganda. Lancet 2004;364:1428-34. PMID:15488218 doi:10.1016/S0140-6736(04)17225-5
12. Were A, Mermin J, Wamai N, Awor A, Bechange S, Moss S, et al. Undiagnosed HIV infection and couple HIV discordance among household members of HIV-infected people receiving antiretroviral therapy in Uganda. J Acquir Immune Defic Syndr 2006;43:91-5. PMID:16885775 doi:10.1097/01.qai. 0000225021.81384.28
13. UNAIDS/WHO Policy Statement on HIV testing. Geneva: UNAIDS/WHO; 2004.
14. Increasing access to HIV testing and counselling. Report of: WHO consultation, 19-21 November 2002, Geneva, Switzerland. Geneva: WHO; 2003.
15. WHO/UNAIDS technical consultation on voluntary HIV counselling and testing: models for implementation and strategies for scaling of VCT services, July 2001, Harare, Zimbabwe. Geneva: UNAIDS/WHO; 2001.
16. Uganda HIV/AIDS Sero-Behavioral Survey. Kampala: Ministry of Health; 2004-2005.
17. Chang LW, Osei-Kwasi M, Boakye D, Aidoo S, Hagy A, Curran J, et al. HIV-1 and HIV-2 seroprevalence and risk factors among hospital outpatients in the Eastern region of Ghana, West Africa. J Acquir Immune Defic Syndr 2002;29:511-6.
18. Fabiani M, Accorsi S, Aleni R, Rizzardini G, Nattabi B, Gabrielli A, et al. Estimating HIV prevalence and the impact of HIV/AIDS on a Ugandan hospital by combining serosurvey data and hospital discharge records. J Acquir Immune Defic Syndr 2003;34:62-6. PMID:14501795 doi:10.1097/00126334-200309010-00009
19. Tembo G, Friesan H, Asiimwe-Okiror G, Moser R, Naamara W, Bakyaita N, et al. Bed occupancy due to HIV/AIDS in an urban hospital medical ward in Uganda. AIDS 1994;8:1169-71. PMID:7986417 doi:10.1097/00002030-199408000-00021
20. HIV prevention in the era of expanded treatment access. Global HIV prevention working group; 2004.
21. Liddicoat RV, Horton NJ, Urban R, Maier E, Christiansen D, Samet JH. Assessing missed opportunities for HIV testing in medical settings. J Gen Intern Med 2004;19:349-56. PMID:15061744 doi:10.1111/j.1525-1497.2004.21251. x
22. Centers for Disease Control and Prevention. Routinely recommended HIV testing at an urban urgent-care clinic, Atlanta, Georgia, 2000. MMWR Morb Mortal Wkly Rep 2001;50:538-41.
23. Centers for Disease Control and Prevention. Voluntary HIV testing as part of routine medical care-Massachusetts, 2002. MMWR Morb Mortal Wkly Rep 2002;53:523-6.
24. Kwesigabo G, Killewo JZ, Sandstrom A, Seage GR, Losina E, Sax PE, et al. Prevalence of HIV infection among hospital patients in north-west Tanzania. AIDS Care 1999;11:87-93. PMID:10434985 doi:10.1080/09540129948225
25. Wanyenze R, Kamya M, Liechty C, Ronald A, Guzman D, Wabwire-Mangen F, et al. Inpatient HIV counselling and testing practices at an urban hospital in Kampala, Uganda. AIDS Behav 2006;10:361-7. doi:10.1007/s10461-005-9035-9
26. Guidance on provider-initiated HIV testing and counselling in health facilities. Geneva: UNAIDS/WHO; 2007.
27. Branson BM, Handsfield HH, Lampe MA, Janssen RS, Taylor AW, Lyss SB, et al. Revised recommendations for HIV testing of adults, adolescents and pregnant women in health care settings. MMWR Recomm Rep 2006;55 RR14;1-17.
28. Creek T, Ntumy R, Seipone K, Smith M, Mogodi M, Smit M, et al. Successful introduction of routine opt-out HIV testing in antenatal care in Botswana. J Acquir Immune Defic Syndr 2007;45:102-7. PMID:17460473 doi:10.1097/QAI. 0b013e318047df88
29. Uganda national policy guidelines for HIV counselling and testing. 2nd ed. Ministry of Health, Republic of Uganda; 2005
30. Walensky RP, Losina E, Steger-Craven KA, Freedberg KA. Identifying undiagnosed human immunodeficiency virus: the yield of routine, voluntary inpatient testing. Arch Intern Med 2002;162:887-92. PMID:11966339 doi:10.1001/archinte.162.8.887
31. Beckwith CG, Flanigan TP, del Rio C, Simmons E, Wing EJ, Carpenter CC, et al. It is time to implement routine, not risk-based HIV testing. Clin Infect Dis 2005;40:1037-40. PMID:15824997 doi:10.1086/428620
32. Integrated Community Based Initiatives (ICOBI) Annual Report. Bushenyi; 2005/2006.
33. Weiser SD, Heisler M, Leiter K, Percy-de Korte F, Tlou S, DeMonner S, et al. Routine HIV testing in Botswana: a population-based study on attitudes, practices, and human rights concerns. PLoS Med 2006;3:e261. PMID:16834458 doi:10.1371/journal.pmed.0030261